Algo version: 0.98b
BerGenBio ASA is listed at the LSE Exchange
BerGenBio ASA [0RU5.L]
LSE Sector: Healthcare Industry:Medical Pharmaceuticals

Is BerGenBio ASA stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, BerGenBio ASA pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid NOK0.285 per share. Over the last 1 times between 2022 and 2022, BerGenBio ASA has paid NOK0.285 with an average of NOK0.29 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for BerGenBio ASA 10 years ago, but if you had invested on Friday 24th of January 2020 when the price was NOK232.41, you would have made a loss of NOK-222.33 per share or -95.66%

Yes, the average daily trading liquidity for BerGenBio ASA is NOK238 757 thousand. You should therefore be able to get in and out of your positions relatively fast.

BerGenBio ASA has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for BerGenBio ASA to be medium [0.7 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.